Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rmr (RMR) Liabilities and Shareholders Equity (2016 - 2025)

Rmr's Liabilities and Shareholders Equity history spans 11 years, with the latest figure at $687.1 million for Q4 2025.

  • For Q4 2025, Liabilities and Shareholders Equity fell 0.81% year-over-year to $687.1 million; the TTM value through Dec 2025 reached $2.7 billion, up 4.8%, while the annual FY2025 figure was $718.2 million, 2.53% up from the prior year.
  • Liabilities and Shareholders Equity for Q4 2025 was $687.1 million at Rmr, down from $718.2 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $724.6 million in Q2 2021 and bottomed at $497.9 million in Q3 2021.
  • The 5-year median for Liabilities and Shareholders Equity is $601.8 million (2023), against an average of $614.8 million.
  • The largest annual shift saw Liabilities and Shareholders Equity decreased 27.87% in 2021 before it rose 20.27% in 2024.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $522.4 million in 2021, then grew by 8.07% to $564.5 million in 2022, then rose by 10.79% to $625.4 million in 2023, then increased by 10.76% to $692.7 million in 2024, then fell by 0.81% to $687.1 million in 2025.
  • Per Business Quant, the three most recent readings for RMR's Liabilities and Shareholders Equity are $687.1 million (Q4 2025), $718.2 million (Q3 2025), and $648.0 million (Q2 2025).